Pfizer Inc (PFE)

[Johnny_C]

True, they did state that. The dramatic rise in PPS had more to do with positive drug sales coupled with tax benefits. They have an 11 percent drop in 2018 tax rate, mostly do to RD credits I suspect.

Celgene had a 9% tax rate benefit. Multi nationals that do about 50% in sales outside of US will see a smaller percentage I suspect. But PFE should get some benefit, not as much as if they did the Allergan deal.

Pfe a great buy on the dips stock. Well over 500 percent total returns if bought at lows in 2009.

https://www.fiercepharma.com/financials/abbvie-hikes-2018-forecast-promises-shareholder-rewards-thanks-to-u-s-tax-changes